{
    "source": "Auto-CORPus (full-text)",
    "date": "20230701",
    "key": "autocorpus_fulltext.key",
    "infons": {},
    "documents": [
      {
        "id": "PMC3841796",
        "inputfile": "PMCdata\\PMC3841796.html",
        "infons": {},
        "passages": [
          {
            "offset": 0,
            "infons": {
              "iao_name_1": "document title",
              "iao_id_1": "IAO:0000305"
            },
            "text": "Microbial communities in the respiratory tract of patients with interstitial lung disease",
            "sentences": [],
            "annotations": [],
            "relations": []
          },
          {
            "offset": 89,
            "infons": {
              "section_title_1": "keywords",
              "iao_name_1": "keywords section",
              "iao_id_1": "IAO:0000630"
            },
            "text": "Sarcoidosis, Immunodeficiency, Bacterial Infection, Respiratory Infection",
            "sentences": [],
            "annotations": [],
            "relations": []
          },
          {
            "offset": 170,
            "infons": {
              "section_title_1": "Abstract",
              "section_title_2": "Background",
              "iao_name_1": "textual abstract section",
              "iao_id_1": "IAO:0000315"
            },
            "text": "Molecular methods based on phylogenetic differences in the 16S rRNA gene are able to characterise the microbiota of the respiratory tract in health and disease.",
            "sentences": [],
            "annotations": [],
            "relations": []
          },
          {
            "offset": 348,
            "infons": {
              "section_title_1": "Abstract",
              "section_title_2": "Objectives",
              "iao_name_1": "textual abstract section",
              "iao_id_1": "IAO:0000315"
            },
            "text": "Our goals were (1) to characterise bacterial communities in lower and upper airways of patients with interstitial lung disease (ILD) and (2) to compare the results with the microbiota of patients with Pneumocystis pneumonia (PCP) and normal controls.",
            "sentences": [],
            "annotations": [],
            "relations": []
          },
          {
            "offset": 608,
            "infons": {
              "section_title_1": "Abstract",
              "section_title_2": "Methods",
              "iao_name_1": "textual abstract section",
              "iao_id_1": "IAO:0000315"
            },
            "text": "We examined the upper and lower respiratory tract of 18 patients with ILD of whom 5, 6, and 7 had idiopathic interstitial pneumonia (IIP), non-IIP and sarcoidosis, respectively. In addition, six immune-compromised patients with PCP and nine healthy subjects were included as controls. Exclusion criteria were recent bacterial/viral respiratory tract infection, HIV-positivity and subjects receiving antibiotic therapy. Bronchoalveolar lavage fluid and oropharyngeal swabs were simultaneously collected, and microbiota was characterised by ultra-deep 16S rRNA gene sequencing.",
            "sentences": [],
            "annotations": [],
            "relations": []
          },
          {
            "offset": 1190,
            "infons": {
              "section_title_1": "Abstract",
              "section_title_2": "Results",
              "iao_name_1": "textual abstract section",
              "iao_id_1": "IAO:0000315"
            },
            "text": "The microbiota in lower airways of the majority of patients (30; 90%) primarily consisted of Prevotellaceae, Streptococcaceae and Acidaminococcaceae. α and β diversity measurements revealed no significant differences in airway microbiota composition between the five different groups of patients. Comparison of bacterial populations in upper and lower respiratory tract showed significant topographical discontinuities for 7 (23%) individuals.",
            "sentences": [],
            "annotations": [],
            "relations": []
          },
          {
            "offset": 1640,
            "infons": {
              "section_title_1": "Abstract",
              "section_title_2": "Conclusions",
              "iao_name_1": "textual abstract section",
              "iao_id_1": "IAO:0000315"
            },
            "text": "IIP, non-IIP and sarcoidosis are not associated with disordered airway microbiota and a pathogenic role of commensals in the disease process is therefore unlikely. Nevertheless, molecular analysis of the topographical microbiota continuity along the respiratory tract may provide additional information to assist management of individual patients.",
            "sentences": [],
            "annotations": [],
            "relations": []
          },
          {
            "offset": 1998,
            "infons": {
              "section_title_1": "Introduction",
              "iao_name_1": "introduction section",
              "iao_id_1": "IAO:0000316"
            },
            "text": "Lower airways in healthy individuals have been considered as being sterile based on conventional microbial culture methods.1\n2 This paradigm has recently been challenged by studies implementing ultra-deep sequencing methods analysing the 16S rRNA gene. In particular, it has been suggested that lower airways might be colonised with ‘symbiotic’ bacteria.3\n4 Furthermore, it has been revealed that a disturbance in the composition of the lower airway microbiota may be associated with chronic lung diseases, such as asthma or chronic obstructive lung disease.3\n5–8",
            "sentences": [],
            "annotations": [],
            "relations": []
          },
          {
            "offset": 2573,
            "infons": {
              "section_title_1": "Introduction",
              "iao_name_1": "introduction section",
              "iao_id_1": "IAO:0000316"
            },
            "text": "A disturbance of the microbiota may also be present in patients with interstitial lung disease (ILD), but so far, this has not yet been investigated. Though it is known that immune-compromised hosts are at increased risk for lower respiratory tract infections, the distinction between non-infectious and infectious causes for deterioration of an ILD patient can be clinically challenging based on conventional microbiological diagnostic techniques.9 An alteration of the airway microbiota in ILD patients may hypothetically be associated with clinical worsening due to immune dysregulation, excessive inflammation and/or infection. The characterisation of microbiota may therefore be of an additional diagnostic value.",
            "sentences": [],
            "annotations": [],
            "relations": []
          },
          {
            "offset": 3291,
            "infons": {
              "section_title_1": "Introduction",
              "iao_name_1": "introduction section",
              "iao_id_1": "IAO:0000316"
            },
            "text": "In the underlying study, we sought to investigate the bacterial microbiota in the upper and lower respiratory tract in patients with ILD. More specifically, we aimed at addressing two objectives: (1) to characterise bacterial communities in lower and upper airways of patients with ILD and (2) to compare the results with the microbiota of patients with Pneumocystis pneumonia (PCP) and normal controls.",
            "sentences": [],
            "annotations": [],
            "relations": []
          },
          {
            "offset": 3694,
            "infons": {
              "section_title_1": "Material and methods",
              "section_title_2": "Study population and definitions",
              "iao_name_1": "materials section",
              "iao_id_1": "IAO:0000633",
              "iao_name_2": "methods section",
              "iao_id_2": "IAO:0000317"
            },
            "text": "The Epidemiology and Clinical Relevance of Infectious Agents in Bronchoalveolar Lavage (ECRIBAL) study is a prospective, single centre observational study investigating new diagnostic methods and potential pathogens in patients with ILD and in immune-compromised patients with suspicion of lung infection. The study has been approved by the local ethics committee (Kantonale Ethikkommission Bern, approval Nr. 153/08).",
            "sentences": [],
            "annotations": [],
            "relations": []
          },
          {
            "offset": 4164,
            "infons": {
              "section_title_1": "Material and methods",
              "section_title_2": "Study population and definitions",
              "iao_name_1": "materials section",
              "iao_id_1": "IAO:0000633",
              "iao_name_2": "methods section",
              "iao_id_2": "IAO:0000317"
            },
            "text": "For the purpose of the current microbiota study and based on the ATS/ERS international multidisciplinary consensus classification,10 we included patients of the following three ILD groups from ECRIBAL: exacerbated idiopathic interstitial pneumonias (IIP) (n=5), exacerbated non-IIP (n=6) and ILD due to sarcoidosis (n=7). Based on this classification, the non-IIP group contained ILD due to known causes, such as collagen vascular disease, environmental, drug related and ‘other’ ILD, for example, eosinophilic pneumonia (see table 1 for details). In addition, we included the following comparative groups: patients with Pneumocystis pneumonia (PCP) (n=6) and healthy controls without evidence for pulmonary or systemic disease (n=9).",
            "sentences": [],
            "annotations": [],
            "relations": []
          }]}]}